Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid

Context

Uncertainty exists about the benefit of dietary docosahexaenoic acid (DHA) on the neurodevelopment of preterm infants.

Objective

To determine the effect of meeting the estimated DHA requirement of preterm infants on neurodevelopment at 18 months' corrected age.

Design, Setting, and Participants

Randomized, double-blind controlled trial enrolling infants born at less than 33 weeks' gestation from April 2001 to...